MX2023004327A - Conjugados terapeuticos radiomarcados y su uso en terapia. - Google Patents
Conjugados terapeuticos radiomarcados y su uso en terapia.Info
- Publication number
- MX2023004327A MX2023004327A MX2023004327A MX2023004327A MX2023004327A MX 2023004327 A MX2023004327 A MX 2023004327A MX 2023004327 A MX2023004327 A MX 2023004327A MX 2023004327 A MX2023004327 A MX 2023004327A MX 2023004327 A MX2023004327 A MX 2023004327A
- Authority
- MX
- Mexico
- Prior art keywords
- compounds
- therapy
- radio
- formula
- therapeutic conjugates
- Prior art date
Links
- 230000001225 therapeutic effect Effects 0.000 title abstract 2
- 238000002560 therapeutic procedure Methods 0.000 title abstract 2
- 150000001875 compounds Chemical class 0.000 abstract 5
- 238000000034 method Methods 0.000 abstract 2
- 125000000217 alkyl group Chemical group 0.000 abstract 1
- 150000002148 esters Chemical class 0.000 abstract 1
- GPSSQIRGCXEBSH-UHFFFAOYSA-N oxoarsenic Chemical group [As]=O GPSSQIRGCXEBSH-UHFFFAOYSA-N 0.000 abstract 1
- 229940002612 prodrug Drugs 0.000 abstract 1
- 239000000651 prodrug Substances 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
- 239000012453 solvate Substances 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
- A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
- A61K51/04—Organic compounds
- A61K51/0497—Organic compounds conjugates with a carrier being an organic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
- C07B59/00—Introduction of isotopes of elements into organic compounds ; Labelled organic compounds per se
- C07B59/004—Acyclic, carbocyclic or heterocyclic compounds containing elements other than carbon, hydrogen, halogen, oxygen, nitrogen, sulfur, selenium or tellurium
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
- A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
- A61K51/04—Organic compounds
- A61K51/0402—Organic compounds carboxylic acid carriers, fatty acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
- A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
- A61K51/04—Organic compounds
- A61K51/08—Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins
- A61K51/088—Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins conjugates with carriers being peptides, polyamino acids or proteins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N5/00—Radiation therapy
- A61N5/10—X-ray therapy; Gamma-ray therapy; Particle-irradiation therapy
- A61N5/1001—X-ray therapy; Gamma-ray therapy; Particle-irradiation therapy using radiation sources introduced into or applied onto the body; brachytherapy
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D255/00—Heterocyclic compounds containing rings having three nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D249/00 - C07D253/00
- C07D255/02—Heterocyclic compounds containing rings having three nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D249/00 - C07D253/00 not condensed with other rings
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Organic Chemistry (AREA)
- Optics & Photonics (AREA)
- Epidemiology (AREA)
- Physics & Mathematics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Pathology (AREA)
- Radiology & Medical Imaging (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Steroid Compounds (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| AU2020903727A AU2020903727A0 (en) | 2020-10-14 | Conjugates and their use in therapy | |
| PCT/AU2021/051203 WO2022077068A1 (en) | 2020-10-14 | 2021-10-14 | Therapeutic radiolabelled conjugates and their use in therapy |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MX2023004327A true MX2023004327A (es) | 2023-08-30 |
Family
ID=81207378
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MX2023004327A MX2023004327A (es) | 2020-10-14 | 2021-10-14 | Conjugados terapeuticos radiomarcados y su uso en terapia. |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US20230398240A1 (cg-RX-API-DMAC7.html) |
| EP (1) | EP4228710A4 (cg-RX-API-DMAC7.html) |
| JP (1) | JP7890301B2 (cg-RX-API-DMAC7.html) |
| KR (1) | KR20230130610A (cg-RX-API-DMAC7.html) |
| CN (1) | CN116472068A (cg-RX-API-DMAC7.html) |
| AU (1) | AU2021359638A1 (cg-RX-API-DMAC7.html) |
| CA (1) | CA3195410A1 (cg-RX-API-DMAC7.html) |
| IL (1) | IL302033A (cg-RX-API-DMAC7.html) |
| MX (1) | MX2023004327A (cg-RX-API-DMAC7.html) |
| WO (1) | WO2022077068A1 (cg-RX-API-DMAC7.html) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20220152229A1 (en) | 2019-04-12 | 2022-05-19 | Centenary Institute Of Cancer Medicine And Cell Biology | Conjugates and their use as imaging agents |
| US20250269072A1 (en) * | 2021-10-14 | 2025-08-28 | Centenary Institute Of Cancer Medicine And Cell Biology | Processes for preparing radiolabelled conjugates |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN100418585C (zh) * | 2003-07-24 | 2008-09-17 | 伯拉考成像股份公司 | 稳定的放射性药物组合物及制备方法 |
| WO2016088116A1 (en) * | 2014-12-05 | 2016-06-09 | University Health Network | Use of antioxidants as radio-protective agents |
| LT3275883T (lt) | 2015-03-25 | 2021-08-25 | Fujifilm Corporation | Naujo azotą turinčio junginio arba jo druskos gamybos būdas ir jo tarpinio junginio gamyba |
| US20160367620A1 (en) * | 2015-06-19 | 2016-12-22 | Harry B. Demopoulos | Glutathione |
| US20220152229A1 (en) * | 2019-04-12 | 2022-05-19 | Centenary Institute Of Cancer Medicine And Cell Biology | Conjugates and their use as imaging agents |
-
2021
- 2021-10-14 CA CA3195410A patent/CA3195410A1/en active Pending
- 2021-10-14 KR KR1020237015744A patent/KR20230130610A/ko active Pending
- 2021-10-14 CN CN202180075143.7A patent/CN116472068A/zh active Pending
- 2021-10-14 JP JP2023547721A patent/JP7890301B2/ja active Active
- 2021-10-14 WO PCT/AU2021/051203 patent/WO2022077068A1/en not_active Ceased
- 2021-10-14 IL IL302033A patent/IL302033A/en unknown
- 2021-10-14 AU AU2021359638A patent/AU2021359638A1/en active Pending
- 2021-10-14 EP EP21878793.5A patent/EP4228710A4/en active Pending
- 2021-10-14 MX MX2023004327A patent/MX2023004327A/es unknown
-
2023
- 2023-04-12 US US18/299,304 patent/US20230398240A1/en active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| CN116472068A (zh) | 2023-07-21 |
| JP7890301B2 (ja) | 2026-07-14 |
| IL302033A (en) | 2023-06-01 |
| KR20230130610A (ko) | 2023-09-12 |
| US20230398240A1 (en) | 2023-12-14 |
| CA3195410A1 (en) | 2022-04-21 |
| EP4228710A4 (en) | 2025-04-09 |
| EP4228710A1 (en) | 2023-08-23 |
| WO2022077068A1 (en) | 2022-04-21 |
| JP2023547954A (ja) | 2023-11-14 |
| AU2021359638A1 (en) | 2023-06-01 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AR120080A1 (es) | Compuestos lipídicos de cola ramificada y composiciones para la administración intracelular de agentes terapéuticos | |
| PE20230238A1 (es) | Inhibidores de kras g12c | |
| PE20251288A1 (es) | Compuestos heterociclicos como inmunomoduladores | |
| AR120680A1 (es) | Tetrahidrofuranos sustituidos como moduladores de canales de sodio | |
| AR034390A1 (es) | Derivados de 1-sulfonil-tetrahidro quinolinas sustituidas, composiciones farmaceuticas y el uso de las mismas para la elaboracion de medicamentos como inhibidores de la gama secretasa | |
| PE20212302A1 (es) | Inhibidores de apol1 y sus metodos de uso | |
| AR125425A1 (es) | Inhibidores de proteina tirosina fosfatasa y sus metodos de uso | |
| MX2024009926A (es) | Composiciones y metodos para tratar trastornos del snc. | |
| AR107154A1 (es) | Estimuladores de guanilato ciclasa soluble | |
| AR083676A1 (es) | Compuestos heterociclicos, útiles como inhibidores de quinasa y composiciones farmaceuticas que los contienen | |
| AR029301A1 (es) | Compuestos derivados de biarilo, metodos para su preparacion composiciones que los contienen, su uso como agonistas en receptores beta-adreno-receptores atipicos | |
| AR120652A1 (es) | Antagonistas de sstr5 | |
| CO6170361A2 (es) | Composiciones y metodos para modular receptores de c-kit y pdgfr | |
| ECSP941102A (es) | Pirazolopirimidinonas para el tratamiento de la impotencia | |
| PE20181924A1 (es) | Inhibidores de la arginasa y sus aplicaciones terapeuticas | |
| PE20242071A1 (es) | Compuestos moduladores de diacilglicerol quinasa | |
| CO6020016A1 (es) | Derivados de 1,2,4,5 tetrahidro-3h-benzapezinas su procedimiento de preparacion y las composiciones farmaceuticas que las contienen | |
| AR063119A1 (es) | Derivados de piridinonas sustituidas, composiciones farmaceuticas que los contienen y usos como antagonistas en trastornos asociados a receptores del tipo i de la hormona de melanina(mch-1 o mchr-1) | |
| AR044006A1 (es) | Compuesto de fenilpiperidinilo, su uso para la fabricacion de un medicamento, composicion farmaceutica que lo comprende y procedimiento para la preparacion de dicho compuesto | |
| AR094496A1 (es) | Compuestos tetracíclicos sustituidos con heterociclo y métodos de uso de los mismos para el tratamiento de enfermedades víricas | |
| AR124189A1 (es) | Compuestos y procedimientos de uso de los mismos | |
| AR117229A1 (es) | Compuestos heteroaromáticos como inhibidores de vanina | |
| UY29312A1 (es) | Piperazin-1-carboxamidas n,4,sustituidas y sus derivados, composiciones que los contienen, procedimientos de preparación y aplicaciones | |
| PE20250457A1 (es) | Compuestos antivirales y metodos de elaboracion y uso de los mismos | |
| MX2022002339A (es) | Derivados de alfa-d-galactopiranosido. |